Role of Noncoding RNAs in Liver Fibrosis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2023 Mar 31

PMID 36998425

Authors

Qing-Yuan Li

Tao Gong

Yi-Ke Huang

Lan Kang

Charlotte A Warner

He Xie

Li-Min Chen

Xiao-Qiong Duan

Affiliations

Soon will be listed here.

Abstract

Liver fibrosis is a wound-healing response following chronic liver injury caused by hepatitis virus infection, obesity, or excessive alcohol. It is a dynamic and reversible process characterized by the activation of hepatic stellate cells and excess accumulation of extracellular matrix. Advanced fibrosis could lead to cirrhosis and even liver cancer, which has become a significant health burden worldwide. Many studies have revealed that noncoding RNAs (ncRNAs), including microRNAs, long noncoding RNAs and circular RNAs, are involved in the pathogenesis and development of liver fibrosis by regulating signaling pathways including transforming growth factor-β pathway, phosphatidylinositol 3-kinase/protein kinase B pathway, and Wnt/β-catenin pathway. NcRNAs in serum or exosomes have been reported to tentatively applied in the diagnosis and staging of liver fibrosis and combined with elastography to improve the accuracy of diagnosis. NcRNAs mimics, ncRNAs in mesenchymal stem cell-derived exosomes, and lipid nanoparticles-encapsulated ncRNAs have become promising therapeutic approaches for the treatment of liver fibrosis. In this review, we update the latest knowledge on ncRNAs in the pathogenesis and progression of liver fibrosis, and discuss the potentials and challenges to use these ncRNAs for diagnosis, staging and treatment of liver fibrosis. All these will help us to develop a comprehensive understanding of the role of ncRNAs in liver fibrosis.

Citing Articles

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis.

Sartorius K, Wang Y, Sartorius B, Antwi S, Li X, Chuturgoon A Funct Integr Genomics. 2025; 25(1):24.

PMID: 39847120 DOI: 10.1007/s10142-024-01519-4.

Signaling pathways that activate hepatic stellate cells during liver fibrosis.

Zhang Y, Ren L, Tian Y, Guo X, Wei F, Zhang Y Front Med (Lausanne). 2024; 11:1454980.

PMID: 39359922 PMC: 11445071. DOI: 10.3389/fmed.2024.1454980.

Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?.

de Pellegars-Malhortie A, Picque Lasorsa L, Mazard T, Granier F, Prevostel C Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065798 PMC: 11279613. DOI: 10.3390/ph17070949.

Pathogenesis and clinical features of severe hepatitis E virus infection.

Orosz L, Sarvari K, Dernovics A, Rosztoczy A, Megyeri K World J Virol. 2024; 13(2):91580.

PMID: 38984076 PMC: 11229844. DOI: 10.5501/wjv.v13.i2.91580.

Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases.

Sisto M, Lisi S J Clin Med. 2024; 13(1).

PMID: 38202170 PMC: 10780256. DOI: 10.3390/jcm13010164.

References

Liu C, Chen L . Circular RNAs: Characterization, cellular roles, and applications. Cell. 2022; 185(12):2016-2034. DOI: 10.1016/j.cell.2022.04.021. View

Xiao Y, Liu R, Li X, Gurley E, Hylemon P, Lu Y . Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia. Hepatology. 2019; 70(5):1658-1673. PMC: 6819224. DOI: 10.1002/hep.30698. View

Wang J, Zhu S, Meng N, He Y, Lu R, Yan G . ncRNA-Encoded Peptides or Proteins and Cancer. Mol Ther. 2019; 27(10):1718-1725. PMC: 6822234. DOI: 10.1016/j.ymthe.2019.09.001. View

Shi S, Song L, Yu H, Feng S, He J, Liu Y . Knockdown of LncRNA-H19 Ameliorates Kidney Fibrosis in Diabetic Mice by Suppressing miR-29a-Mediated EndMT. Front Pharmacol. 2020; 11:586895. PMC: 7725869. DOI: 10.3389/fphar.2020.586895. View

Cui W, Zhou S, Wang Y, Shi X, Liu H . Cadmium exposure activates the PI3K/AKT signaling pathway through miRNA-21, induces an increase in M1 polarization of macrophages, and leads to fibrosis of pig liver tissue. Ecotoxicol Environ Saf. 2021; 228:113015. DOI: 10.1016/j.ecoenv.2021.113015. View

Ma Y, Yuan X, Han M, Xu Y, Han K, Liang P . miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGFβ receptor 1. Hepatol Int. 2022; 16(3):614-626. DOI: 10.1007/s12072-021-10277-5. View

Wang T, Zhang C, Meng X, Zhu B, Wang S, Yuan W . Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway. Front Physiol. 2022; 13:792182. PMC: 8882958. DOI: 10.3389/fphys.2022.792182. View

Azar F, Courtet K, Dekky B, Bonnier D, Dameron O, Colige A . Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease. Liver Int. 2020; 40(8):2021-2033. DOI: 10.1111/liv.14476. View

Pan Q, Guo C, Xu Q, Wang J, Li H, Fang C . miR-16 integrates signal pathways in myofibroblasts: determinant of cell fate necessary for fibrosis resolution. Cell Death Dis. 2020; 11(8):639. PMC: 7429878. DOI: 10.1038/s41419-020-02832-z. View

10.

Huang W, Huang F, Zhang R, Luo H . LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate . Cell Cycle. 2021; 20(5-6):490-507. PMC: 8018424. DOI: 10.1080/15384101.2021.1875665. View

11.

Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M . microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis. Front Physiol. 2012; 3:49. PMC: 3307137. DOI: 10.3389/fphys.2012.00049. View

12.

Zhu S, Chen X, Wang J, Xu J, Wang A, Li J . Circular RNA circUbe2k promotes hepatic fibrosis via sponging miR-149-5p/TGF-β2 axis. FASEB J. 2021; 35(6):e21622. DOI: 10.1096/fj.202002738R. View

13.

Wang W, Dong R, Guo Y, He J, Shao C, Yi P . CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7. J Cell Mol Med. 2019; 23(8):5486-5496. PMC: 6653252. DOI: 10.1111/jcmm.14432. View

14.

Luo X, Luo S, Xu Z, Zhou C, Li Z, Zhou X . Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World J Gastroenterol. 2021; 27(14):1419-1434. PMC: 8047533. DOI: 10.3748/wjg.v27.i14.1419. View

15.

Younossi Z . Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2018; 70(3):531-544. DOI: 10.1016/j.jhep.2018.10.033. View

16.

Feng Y, Li Y, Xu M, Meng H, Dai C, Yao Z . Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis. Stem Cell Res Ther. 2022; 13(1):375. PMC: 9331515. DOI: 10.1186/s13287-022-03069-7. View

17.

Zhang K, Shi Z, Zhang M, Dong X, Zheng L, Li G . Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020; 11(2):132. PMC: 7028920. DOI: 10.1038/s41419-020-2323-5. View

18.

Zou L, Shi C, Wang D, Cheng J, Wang Q, Wang L . Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis. Bioengineered. 2022; 13(3):6150-6162. PMC: 8973981. DOI: 10.1080/21655979.2022.2037841. View

19.

Zhou Q, Yang H, Liu J, Xu N, Li J, Shen L . MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7. Parasit Vectors. 2021; 14(1):472. PMC: 8442346. DOI: 10.1186/s13071-021-04972-3. View

20.

Wang N, Li X, Zhong Z, Qiu Y, Liu S, Wu H . 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. J Nanobiotechnology. 2021; 19(1):437. PMC: 8686281. DOI: 10.1186/s12951-021-01138-2. View